X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (33133) 33133
Book Chapter (520) 520
Dissertation (188) 188
Publication (116) 116
Conference Proceeding (61) 61
Magazine Article (49) 49
Newsletter (39) 39
Book / eBook (27) 27
Web Resource (18) 18
Newspaper Article (4) 4
Journal / eJournal (3) 3
Streaming Video (3) 3
Government Document (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28662) 28662
science & technology (22452) 22452
life sciences & biomedicine (21871) 21871
male (15597) 15597
female (14791) 14791
child (13515) 13515
oncology (10936) 10936
hematology (10901) 10901
adolescent (10476) 10476
child, preschool (9326) 9326
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (8184) 8184
adult (8179) 8179
acute lymphoblastic leukemia (7289) 7289
precursor cell lymphoblastic leukemia-lymphoma - genetics (6677) 6677
infant (5819) 5819
leukemia (5234) 5234
precursor cell lymphoblastic leukemia-lymphoma - pathology (5037) 5037
middle aged (4861) 4861
precursor cell lymphoblastic leukemia-lymphoma - therapy (4728) 4728
pediatrics (4640) 4640
prognosis (4030) 4030
antineoplastic combined chemotherapy protocols - therapeutic use (3464) 3464
cancer (3323) 3323
precursor cell lymphoblastic leukemia-lymphoma - complications (3179) 3179
acute lymphocytic leukemia (3125) 3125
treatment outcome (2988) 2988
abridged index medicus (2922) 2922
precursor cell lymphoblastic leukemia-lymphoma - diagnosis (2833) 2833
aged (2763) 2763
risk factors (2719) 2719
children (2519) 2519
precursor cell lymphoblastic leukemia-lymphoma - mortality (2508) 2508
chemotherapy (2438) 2438
animals (2371) 2371
remission induction (2353) 2353
recurrence (2258) 2258
precursor cell lymphoblastic leukemia-lymphoma - metabolism (2093) 2093
precursor cell lymphoblastic leukemia-lymphoma - immunology (2088) 2088
research (2033) 2033
young adult (2010) 2010
retrospective studies (1979) 1979
acute lymphatic leukemia (1785) 1785
care and treatment (1718) 1718
antineoplastic agents - therapeutic use (1585) 1585
transplantation (1585) 1585
genetic aspects (1578) 1578
mice (1568) 1568
follow-up studies (1566) 1566
health aspects (1547) 1547
immunophenotyping (1535) 1535
flow cytometry (1506) 1506
disease-free survival (1505) 1505
analysis (1494) 1494
precursor cell lymphoblastic leukemia-lymphoma - blood (1456) 1456
immunology (1447) 1447
hemic and lymphatic diseases (1431) 1431
acute disease (1416) 1416
cell line, tumor (1399) 1399
survival rate (1393) 1393
bone marrow transplantation (1349) 1349
precursor cell lymphoblastic leukemia-lymphoma - epidemiology (1295) 1295
gene expression (1257) 1257
combined modality therapy (1255) 1255
time factors (1239) 1239
lymphatic leukemia (1236) 1236
translocation, genetic (1234) 1234
acute lymphoblastic leukaemia (1223) 1223
polymerase chain reaction (1211) 1211
antineoplastic combined chemotherapy protocols - adverse effects (1201) 1201
infant, newborn (1179) 1179
mutation (1162) 1162
transplantation, homologous (1161) 1161
hematopoietic stem cell transplantation (1133) 1133
apoptosis (1131) 1131
survival analysis (1088) 1088
bone marrow (1085) 1085
philadelphia chromosome (1078) 1078
tumor cells, cultured (1065) 1065
case-control studies (1054) 1054
bone marrow - pathology (1049) 1049
cell biology (1037) 1037
all (1017) 1017
medicine & public health (1015) 1015
precursor b-cell lymphoblastic leukemia-lymphoma - genetics (1009) 1009
genetics & heredity (1007) 1007
methotrexate - administration & dosage (1003) 1003
general & internal medicine (977) 977
karyotyping (965) 965
medicine, general & internal (963) 963
stem cells (963) 963
hematology, oncology and palliative medicine (938) 938
pathology (890) 890
minimal residual disease (881) 881
biochemistry & molecular biology (880) 880
precursor b-cell lymphoblastic leukemia-lymphoma - pathology (876) 876
patients (866) 866
t cells (857) 857
diagnosis (855) 855
antineoplastic agents - adverse effects (852) 852
acute leukemia (845) 845
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (31364) 31364
Chinese (997) 997
Japanese (606) 606
Spanish (445) 445
French (396) 396
Polish (359) 359
Russian (325) 325
German (301) 301
Portuguese (169) 169
Italian (89) 89
Czech (73) 73
Turkish (45) 45
Korean (38) 38
Hungarian (33) 33
Danish (31) 31
Dutch (26) 26
Persian (22) 22
Norwegian (20) 20
Serbian (17) 17
Slovak (12) 12
Croatian (11) 11
Ukrainian (10) 10
Arabic (8) 8
Finnish (8) 8
Romanian (8) 8
Swedish (7) 7
Hebrew (5) 5
Slovenian (4) 4
Bosnian (3) 3
Indonesian (3) 3
Bulgarian (1) 1
Greek (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 1528-0020, 08/2011, Volume 118, Issue 8, pp. 2077 - 2084
Journal Article
Haematologica (Roma), ISSN 1592-8721, 05/2007, Volume 92, Issue 5, pp. 612 - 618
From the Hematology and Bone Marrow Transplantation Units of Ospedali Riuniti Bergamo (OS, BP, MT, VG, AS, MCZ, EO, AG, TI, CM, TB, RB, AR); Spedali Civili... 
ALL | Allogeneic transplantation | MRD | Adult ALL | Life Sciences & Biomedicine | Hematology | Science & Technology | Translocation, Genetic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Humans | Middle Aged | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - surgery | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Leukemia-Lymphoma, Adult T-Cell - drug therapy | Gene Deletion | Fusion Proteins, bcr-abl - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - blood | Precursor Cell Lymphoblastic Leukemia-Lymphoma - blood | Basic Helix-Loop-Helix Transcription Factors - genetics | Hematopoietic Stem Cell Transplantation | Survival Rate | Combined Modality Therapy | Remission Induction | Adolescent | Survival Analysis | Oncogene Proteins, Fusion - blood | Kinetics | Transplantation Conditioning | Cohort Studies | Piperazines - administration & dosage | Clinical Trials as Topic - statistics & numerical data | Precursor Cell Lymphoblastic Leukemia-Lymphoma - surgery | Risk | Transplantation, Homologous | Neoplasm, Residual | Multicenter Studies as Topic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - mortality | Polymerase Chain Reaction | Adult | Female | Myeloid-Lymphoid Leukemia Protein - blood | Gene Rearrangement, B-Lymphocyte | Precursor Cell Lymphoblastic Leukemia-Lymphoma - pathology | T-Cell Acute Lymphocytic Leukemia Protein 1 | Leukemia-Lymphoma, Adult T-Cell - genetics | Leukemia-Lymphoma, Adult T-Cell - surgery | Pyrimidines - administration & dosage | Gene Rearrangement, T-Lymphocyte | Leukemia-Lymphoma, Adult T-Cell - mortality | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Treatment Outcome | Leukemia-Lymphoma, Adult T-Cell - pathology | Imatinib Mesylate | Biomarkers, Tumor - blood | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Leukemia-Lymphoma, Adult T-Cell - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Benzamides | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2013, Volume 31, Issue 34, pp. 4333 - 4342
Journal Article
Leukemia & lymphoma, ISSN 1029-2403, 02/2011, Volume 52, Issue 6, pp. 1098 - 1107
Monoclonal antibody (MoAb)-based therapies have opened innovative treatment avenues that have impacted on the management of patients with both neoplastic and... 
mean fluorescence intensity (MFI) | monoclonal antibody therapy | antigen expression | antibody binding capacity (ABC) | Acute lymphoid leukemia (ALL) | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Antigens, CD - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Flow Cytometry - methods | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - pathology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Humans | Middle Aged | Child, Preschool | Antibodies, Monoclonal - therapeutic use | Sialic Acid Binding Ig-like Lectin 2 - immunology | Antigens, CD - metabolism | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Sialic Acid Binding Ig-like Lectin 2 - metabolism | Aged, 80 and over | Adult | Transcription, Genetic | Sialic Acid Binding Ig-like Lectin 3 | Child | Antibodies, Monoclonal - immunology | Antigens, Differentiation, Myelomonocytic - immunology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Antigens, CD19 - immunology | Antigens, CD20 - immunology | Immunophenotyping | Antigens, CD20 - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Reverse Transcriptase Polymerase Chain Reaction | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Oncogene Proteins, Fusion - genetics | Antigens, Differentiation, Myelomonocytic - metabolism | Adolescent | Aged | Antigens, CD19 - metabolism | Index Medicus
Journal Article
Leukemia, ISSN 1476-5551, 11/2008, Volume 23, Issue 3, pp. 557 - 564
Myelotoxicity during thiopurine therapy is enhanced in patients, who because of single nucleotide polymorphisms have decreased activity of the enzyme... 
Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - epidemiology | Recurrence | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Antimetabolites, Antineoplastic - pharmacokinetics | Humans | Neoplasm Proteins - physiology | Methyltransferases - genetics | Child, Preschool | Infant | Male | Risk | Antimetabolites, Antineoplastic - administration & dosage | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Methyltransferases - physiology | Female | Neoplasms, Second Primary - genetics | Neoplasm Proteins - genetics | Child | Mercaptopurine - pharmacokinetics | Scandinavian and Nordic Countries - epidemiology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - enzymology | Mercaptopurine - administration & dosage | Genotype | Neoplasms, Second Primary - enzymology | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - enzymology | Methyltransferases - analysis | Neoplasms, Second Primary - epidemiology | Polymorphism, Genetic | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - epidemiology | Thioguanine - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Thioguanine - pharmacokinetics | Biotransformation - drug effects | Neoplasm Proteins - analysis | Inactivation, Metabolic - genetics | DNA Damage | Methylation | Methyltransferases | Physiological aspects | Genetic aspects | Acute lymphocytic leukemia | Research | Single nucleotide polymorphisms | Risk factors | Index Medicus | thiopurine methyltransferase | genetic polymorphisms | acute lymphoblastic leukemia | second malignant neoplasm | relapse rate
Journal Article